Concepedia

Zhiguang Xiao

ZX

Statistics

Publications

7

Citations

191

H-Index

7

Active since

2011

Affiliations

Max Planck Institute of Biochemistry(Current)

National Cancer Institute

National Institutes of Health

Zhiguang Xiao is an author at Max Planck Institute of Biochemistry specializing in oncology, medicine, and molecular oncology.

Publications per year

2011–2024

7

Publications

7

Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status

Zhiguang Xiao, Bianca Sperl, Axel Ullrich et al. · Oncotarget · 2014 · 55 citations · Full text

Medicine, Oncology, Pharmacology +17

Metformin Triggers Autophagy to Attenuate Drug-Induced Apoptosis in NSCLC Cells, with Minor Effects on Tumors of Diabetic Patients

Zhiguang Xiao, Silvia Gaertner, Alicia Morresi‐Hauf et al. · Neoplasia · 2017 · 42 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Building a translational cancer dependency map for The Cancer Genome Atlas

Xu Shi, Christos Gekas, Daniel Verduzco et al. · Nature Cancer · 2024 · 28 citations · Full text

Medicine, Cancer Biology, Oncology +17

Attenuation of Myeloid-Specific TGFβ Signaling Induces Inflammatory Cerebrovascular Disease and Stroke

M. Christine Hollander, Lawrence L. Latour, Dan Yang et al. · Circulation Research · 2017 · 22 citations · Full text

Life Sciences, Immunology, Neuroscience +17

Loss of tumor suppressors promotes inflammatory tumor microenvironment and enhances LAG3+T cell mediated immune suppression

Sara Zahraeifard, Zhiguang Xiao, Jae Young So et al. · Nature Communications · 2024 · 21 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 7